Correlation Between ZyVersa Therapeutics and Elevation Oncology
Can any of the company-specific risk be diversified away by investing in both ZyVersa Therapeutics and Elevation Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ZyVersa Therapeutics and Elevation Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ZyVersa Therapeutics and Elevation Oncology, you can compare the effects of market volatilities on ZyVersa Therapeutics and Elevation Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ZyVersa Therapeutics with a short position of Elevation Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of ZyVersa Therapeutics and Elevation Oncology.
Diversification Opportunities for ZyVersa Therapeutics and Elevation Oncology
0.52 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between ZyVersa and Elevation is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding ZyVersa Therapeutics and Elevation Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elevation Oncology and ZyVersa Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ZyVersa Therapeutics are associated (or correlated) with Elevation Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elevation Oncology has no effect on the direction of ZyVersa Therapeutics i.e., ZyVersa Therapeutics and Elevation Oncology go up and down completely randomly.
Pair Corralation between ZyVersa Therapeutics and Elevation Oncology
Given the investment horizon of 90 days ZyVersa Therapeutics is expected to generate 1.18 times more return on investment than Elevation Oncology. However, ZyVersa Therapeutics is 1.18 times more volatile than Elevation Oncology. It trades about -0.08 of its potential returns per unit of risk. Elevation Oncology is currently generating about -0.15 per unit of risk. If you would invest 425.00 in ZyVersa Therapeutics on August 24, 2024 and sell it today you would lose (311.00) from holding ZyVersa Therapeutics or give up 73.18% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
ZyVersa Therapeutics vs. Elevation Oncology
Performance |
| Timeline |
| ZyVersa Therapeutics |
| Elevation Oncology |
ZyVersa Therapeutics and Elevation Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ZyVersa Therapeutics and Elevation Oncology
The main advantage of trading using opposite ZyVersa Therapeutics and Elevation Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ZyVersa Therapeutics position performs unexpectedly, Elevation Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elevation Oncology will offset losses from the drop in Elevation Oncology's long position.| ZyVersa Therapeutics vs. Cns Pharmaceuticals | ZyVersa Therapeutics vs. Immix Biopharma | ZyVersa Therapeutics vs. Hepion Pharmaceuticals | ZyVersa Therapeutics vs. Zura Bio Limited |
| Elevation Oncology vs. Ocean Biomedical | Elevation Oncology vs. Zura Bio Limited | Elevation Oncology vs. Enveric Biosciences | Elevation Oncology vs. Hepion Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |